Tyrosine Kinase Inhibitors in CML

Key Takeaways

• Personalized treatment strategies have advanced the management of lung cancer brain metastases, improving patient outcomes.
• Targeted therapies and immunotherapies offer effective, less invasive alternatives to traditional treatment methods.
• The roles of stereotactic radiosurgery and whole-brain radiotherapy are evolving with novel systemic therapies.
• Multidisciplinary approaches optimize treatment plans by considering genetic mutations, patient status, and disease extent.